Neuroimmune perturbations and vascular inflammation observed in people with COVID-19
may warrant investigation of immune-modulating interventions to ameliorate neurological …

Some respiratory viruses have long been known to cause neurological involvement. A novel
coronavirus, leading to severe acute respiratory syndrome, also called coronavirus disease …

The recent coronavirus disease of 2019 (COVID-19) pandemic has adversely affected
people worldwide. A growing body of literature suggests the neurological complications and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is
responsible for the outbreak of coronavirus disease 19 (COVID-19) and was first identified in …

Novel coronavirus (severe acute respiratory syndrome coronavirus-2: SARS-CoV-2) has a
high homology with other cousin of coronaviruses such as SARS and Middle East …

The world is experiencing one of the major viral outbreaks of this millennium, caused by a
plus sense single-stranded RNA virus belonging to the Coronaviridae family, COVID-19 …

As the current understanding of COVID-19 continues to evolve, a synthesis of the literature
on the neurological impact of this novel virus may help inform clinical management and …

The coronavirus disease-19 (COVID-19) elicited by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has caused devastating health, economic and social impact …

Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), can cause …

COVID-19 is a highly infectious viral disease caused by the novel coronavirus SARS-CoV-2.
While it was initially regarded as a strictly respiratory illness, the impact of COVID-19 on …